Zobrazeno 1 - 10
of 942
pro vyhledávání: '"Intravenous drug use"'
Publikováno v:
International Medical Case Reports Journal, Vol Volume 17, Pp 855-860 (2024)
Heiler Lozada-Ramos,1– 3 Jorge Álvarez-Payares,4 Jorge Enrique Daza-Arana,2,5 Luisa María Salas-Marín4 1Medicine Program, School of Health, Universidad Santiago de Cali, Palmira, Colombia; 2Movement and Health Research Group, School of Health, U
Externí odkaz:
https://doaj.org/article/d800febd5744415187f0b036946baca9
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-8 (2024)
Abstract Background In Pittsburgh, PA, legal changes in recent decades have set the stage for an expanded role for community pharmacists to provide harm reduction services, including distributing naloxone and non-prescription syringes (NPS). In the w
Externí odkaz:
https://doaj.org/article/7c763b0c761b4a9682c5bac522db87c4
Autor:
John Bowling, Erick Zoumberakis
Publikováno v:
POCUS Journal, Vol 9, Iss 2 (2024)
Performing an ultrasound-guided nerve block (UGNB) is now common practice in many emergency departments (EDs) and is considered a core skill according to the American College of Emergency Physicians (ACEP). Nerve blocks are mostly utilized for fractu
Externí odkaz:
https://doaj.org/article/bf67d0f1794d47a7a3c5f918e2f47b95
Publikováno v:
Addictive Behaviors Reports, Vol 19, Iss , Pp 100546- (2024)
Introduction: Individuals with opioid use disorder (OUD) who inject drugs have an elevated risk of experiencing serious injection-related infections. While such infections can be treated, treatment for the underlying OUD is often limited. One potenti
Externí odkaz:
https://doaj.org/article/fdd43f3e2ba74759bf5c03fe63223a86
Autor:
Tatiana M. Barrera, BA, Omar Venegas, BS, Tiaranesha Jackson, MPH, Yacine Sow, BA, Christopher I. Wachuku, MS, Rosalie Elenitsas, MD, Susan Taylor, MD, Nicholas Mollanazar, MD, MBA
Publikováno v:
JAAD Case Reports, Vol 40, Iss , Pp 80-83 (2023)
Externí odkaz:
https://doaj.org/article/89b04447e9ca498c838b028f84b761b2
Autor:
Hamidreza Karimi-Sari, Gregory M. Lucas, Katie Zook, Brian Weir, Miles Landry, Susan G. Sherman, Kathleen R. Page, Oluwaseun Falade-Nwulia
Publikováno v:
Viruses, Vol 16, Iss 9, p 1416 (2024)
Background: Hepatitis C virus (HCV) infection and hazardous alcohol use are both preventable causes of morbidity and mortality among people who inject drugs (PWID). In the general population, hazardous alcohol is associated with a reduced likelihood
Externí odkaz:
https://doaj.org/article/40e02195a4ac43919a0b717741fbf127
Autor:
Laura E. Biederman, Alana D. Dasgupta, Darren E. Dreyfus, Tibor Nadasdy, Anjali A. Satoskar, Sergey V. Brodsky
Publikováno v:
Glomerular Diseases, Vol 3, Iss 1, Pp 165-177 (2023)
Amyloidosis is an infiltrative disease caused by misfolded proteins depositing in tissues. Amyloid infiltrates the kidney in several patterns. There are, as currently described by the International Society of Amyloidosis, 14 types of amyloid that can
Externí odkaz:
https://doaj.org/article/552df2a5dbed4d60a697a2f7352f19e7
Autor:
Anmol Desai, Lauren O’Neal, Kia Reinis, Cristal Brown, Michael Stefanowicz, Audrey Kuang, Deepak Agrawal, Darlene Bhavnani, Tim Mercer
Publikováno v:
Implementation Science Communications, Vol 4, Iss 1, Pp 1-17 (2023)
Abstract Background Hepatitis C virus (HCV) is a leading cause of liver-related mortality and morbidity. Despite effective direct acting antivirals and a simplified treatment algorithm, limited access to HCV treatment in vulnerable populations, inclu
Externí odkaz:
https://doaj.org/article/05ca76efa3a74da48476a8af791f907f
Publikováno v:
AJOG Global Reports, Vol 4, Iss 1, Pp 100317- (2024)
BACKGROUND: Accurately identifying cases of hepatitis C virus has important medical and public health consequences. In the setting of rising hepatitis C virus prevalence and highly effective treatment with direct-acting antivirals, the Society for Ma
Externí odkaz:
https://doaj.org/article/128dc29456ed4f08aab267449337f032
Autor:
Anmol Desai, Lauren O’Neal, Kia Reinis, Patrick Chang, Cristal Brown, Michael Stefanowicz, Audrey Kuang, Deepak Agrawal, Darlene Bhavnani, Tim Mercer
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Background Hepatitis C virus (HCV) is the leading indication for liver transplantation and liver-related mortality. The development of direct-acting antivirals (DAA) and a simplified treatment algorithm with a > 97% cure rate should make glo
Externí odkaz:
https://doaj.org/article/0d1389335f88420f909a2dc2dc968b78